Ladanyi M - Memorial Sloan-Kettering Cancer Center
Mesothelioma Cancer Expert at Memorial Sloan-Kettering Cancer Center, New York, NY
Mesothelioma Cancer Expert - Ladanyi M - Current Listing of Published Papers
The following is a listing of research papers by Ladanyi M in the field of mesothelioma cancer.
| Ladanyi M. Implications of P16/CDKN2A deletion in pleural mesotheliomas. Lung Cancer. 2005 Jul;49 Suppl 1:S95-8. Epub 2005 Apr 14. Pubmed 15950811 Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. [mskcc.org] |
| Illei PB, Ladanyi M, Rusch VW, Zakowski MF. The use of CDKN2A deletion as a diagnostic marker for malignant mesothelioma in body cavity effusions. Cancer. 2003 Feb 25;99(1):51-6. Pubmed 12589646 Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. |
| Lopez-Rios F, Chuai S, Flores R, Shimizu S, Ohno T, Wakahara K, Illei PB, Hussain S, Krug L, Zakowski MF, Rusch V, Olshen AB, Ladanyi M. Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res. 2006 Mar 15;66(6):2970-9. Pubmed 16540645 Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. |
| Lopez-Rios F, Illei PB, Rusch V, Ladanyi M. Evidence against a role for SV40 infection in human mesotheliomas and high risk of false-positive PCR results owing to presence of SV40 sequences in common laboratory plasmids. Lancet. 2004 Sep 25-Oct 1;364(9440):1157-66. Pubmed 15451223 Department of Pathology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA. |
| Illei PB, Rusch VW, Zakowski MF, Ladanyi M. Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas. Clin Cancer Res. 2003 Jun;9(6):2108-13. Pubmed 12796375 Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, 10021, USA. |
